BiotechTube

HTL0018318 + Placebo oral capsule

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
32
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Safety Issues

Conditions

Safety Issues, Pharmacokinetics

Trial Timeline

May 16, 2017 โ†’ Aug 20, 2017

NCT ID
NCT03198624

About HTL0018318 + Placebo oral capsule

HTL0018318 + Placebo oral capsule is a phase 1 stage product being developed by Nxera Pharma for Safety Issues. The current trial status is completed. This product is registered under clinical trial identifier NCT03198624. Target conditions include Safety Issues, Pharmacokinetics.

Hype Score Breakdown

Clinical
10
Activity
5
Company
9
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT03198624Phase 1Completed

Competing Products

20 competing products in Safety Issues

See all competitors
ProductCompanyStageHype Score
LPH-5 + PlaceboBiotrialPhase 1
25
DS-1971 + placeboDaiichi SankyoPhase 1
33
ASP7962 + PlaceboAstellas PharmaPhase 1
33
ASP2151 + Valacyclovir + PlaceboAstellas PharmaPhase 1
33
AZD7986, oral solution, 1 to 50 mg/mL + Placebo, oral solutionAstraZenecaPhase 1
33
Anifrolumab SC injection (300mg) + Anifrolumab IV infusion (300mg) + Anifrolumab SC infusion (600mg) + Anifrolumab placebo SC injection (300mg) + Anifrolumab placebo IV infusion (300mg) + Anifrolumab placebo SC infusion (600mg)AstraZenecaPhase 1
33
AZD7594 + Placebo to matchAstraZenecaPhase 1
33
Anastrozole ODF + Arimidex tablet + Anastrozole ODF + Arimidex tabletAstraZenecaPhase 1
33
AZD4721 Solution + AZD4721 Placebo + AZD4721 SuspensionAstraZenecaPhase 1
33
AZD9977, oral suspension + Placebo, oral suspension + AZD9977, oral solutionAstraZenecaPhase 1
33
AZD3043AstraZenecaPhase 1
33
AZD8848 + Placebo to match AZD8848AstraZenecaPhase 1
33
AZD9567 Monohydrat + Placebo oral suspension/ Placebo capsule + PrednisoloneAstraZenecaPhase 1
33
AZD7503 + PlaceboAstraZenecaPhase 1
33
Fluad + SalineNovartisApproved
85
TBM100NovartisApproved
85
VIB9600 + PlacebosAmgenPhase 1
32
DenosumabAmgenPhase 3
76
Cadonilimab Combined Albumin-paclitaxel, Cisplatin and FluorouracilAkesoPhase 2
51
Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + PlaceboBayerApproved
82

Other Products from Nxera Pharma

Daridorexant + PlaceboPhase 3
76
HTL0018318 + PlaceboPhase 2
51
HTL0039732 Capsules + HTL0039732 Capsules and atezolizumab infusionPhase 1/2
40
HTL0009936 + HTL0009936 matching placeboPhase 1
32
HTL0018318Phase 1
32